 Canid | Company operating in Consumer. | |
 CANOA | PropTech company. | |
 Canonic Security | Cybersecurity company. | |
 Canopy Servicing | Canopy Servicing operates in Fintech. | |
 Canva | Canva operates in Enterprise Software. | |
 Canvas | SaaS company. | |
 Canvas Medical | Company operating in Healthcare. | |
 Canvass | AI company. | |
 Capacity Bio | Develops medicines that restore mitochondrial quality by inducing mitophagy, the process that removes and replaces damaged mitochondria. Its research includes small molecules, peptides and nanoparticles designed to activate clearance pathways and address mitochondrial dysfunction associated with disease and aging. | |
 Capalo AI | Company operating in AI. | |
 Capchase | Capchase operates in Fintech. | |
 Cape | Cape operates in Cybersecurity. | |
 Cape AI | Cape AI operates in AI. | |
 Cape Analytics | Data & Analytics company. | |
 Capella Space | Defense & Space company. | |
 Caper | SaaS company. | |
 CapGrid | Company operating in Logistics & Supply Chain. | |
 Capi | Capi Money is a payments platform that helps importers in emerging markets pay international suppliers and manage cross-border trade payments. | |
 Capi | Capi Money is a payments platform that helps importers in emerging markets pay international suppliers and manage cross-border trade payments. | |
 Capi | | |
 Capi Money | We closed a Series A last year (Creandum leading, with YC + fmc doubling down) and are processing over $1B a year, with 3 more pay-in markets in 2026. | |
 Capillary Technologies | | |
 Capital Asset Exchange & Trading, LLC | Container xChange helps logistics companies buy, sell, and lease shipping containers worldwide on a trusted marketplace, with tools for tracking, partner vetting, and secure payments. Headquartered in Hamburg, the company serves thousands of members across global hubs. | 🇩🇪 · Germany |
 Capital Rx | Fintech company. | |
 Capitola | | |
 Capitolis | | |
 Capmo | Capmo operates in Construction. | |
 Capsida Biotherapeutics | Capsida Biotherapeutics Inc. is a Thousand Oaks, California biotechnology company developing engineered adeno-associated virus capsids and targeted genetic medicines for neurological and ocular diseases. Originating in Viviana Gradinaru’s Caltech laboratory, its platform combines high-throughput capsid screening, biological-barrier targeting, therapeutic cargo development and gene-therapy manufacturing. It researches intravenous brain delivery and less invasive intravitreal/suprachoroidal ocular delivery. As of its May2026 primary update, Capsida closed the CAP-002 SYNRGY STXBP1 developmental/epileptic encephalopathy trial following the first treated patient’s September2025 death from cerebral edema; the underlying cause remained unresolved. It also announced closure of its CAP-003 Parkinson’s/GBA trial, in which no patients were dosed. Its next-generation RECK-receptor CNS capsid work and ocular programs remain preclinical research, not approved medicines or proven human efficacy. The current directory names Mina Kim executive chair, Romuald Corbau chief scientific officer, Amar Duvvur COO/CFO and co-founder Nicholas Flytzanis research/innovation chief. Current board members and separately qualified founders/historical2025 affiliations are included. Funding includes a50MSeriesA backed by Versant and Westlake, confirmed10MAbbVie equity, and12MNEURO.VC convertible-note financing. Commercial collaborations with AbbVie, Prevail/Lilly, CRISPR and Kate are distinguished from equity; upfront licensing payments, possible future investments, milestones, royalties and cumulative funding totals are not treated as additional closed priced rounds. | Thousand Oaks, California, United States |
 Capstan | Healthcare company. | |
 Capsule | Company operating in Healthcare. | |
 Caption | Fintech company. | Paris, FR |
 Caption Health | Healthcare company. | |
 Captions | | |
 CaptivateIQ | CaptivateIQ operates in SaaS. | |
 Capture | Data & Analytics company. | |
 CapWay | | |
 Car360 | Company operating in E-Commerce & Marketplace. | |
 Cara | Develops conversational AI for remote health and home assessments, helping care organizations evaluate risks, document needs and coordinate benefits for older and at-risk patients. | |
 Carats & Cake | | |
 Caravel Bio | Caravel Bio is a Portland, Oregon synthetic-biology company developing an integrated platform for protein discovery, engineering and delivery. It combines cell-free protein synthesis, bacterial spore display and high-throughput directed evolution to create robust industrial proteins and machine-learning training datasets. Research applications include enzyme-based carbon capture, biochemical manufacturing, DNA synthesis and animal health. Founder and CEO Trevor Nicks developed the underlying technology in research at Tufts University; its current official roster includes nine named team members. In October 2025, Caravel announced a $1.9 million pre-seed round from 2048 Ventures, The Venture Collective, Pioneer Fund and Portland Seed Fund, alongside an NSF CFIRE PRESENT award with an estimated total of $7.8 million supporting a collaborative project led by Caravel. Federal records distinguish that estimated award ceiling from $5,521,174 obligated as of the reviewed record. It also received a $275,000 NSF SBIR Phase I grant and a 2026 Phase II award estimated at $1,246,984, of which $311,746 was initially obligated. Caravel joined Shell GameChanger in July 2025 and disclosed funding for carbon-capture research in May 2026, with the amount undisclosed. Research collaborators and program participants are not automatically company employees or equity investors. | |
 Carbelim | Develops microalgae-based carbon capture and air-purification systems for buildings, public spaces and industrial facilities. Its photobioreactors combine biological treatment with environmental sensors and monitoring software. | |
 Carbmee | Climate & Energy company. | |
 Carbo Culture | Carbo Culture operates in Climate & Energy. | |
 Carbon | Healthcare company. | |
 Carbon Black | | |
 Carbon Blue | Company operating in Climate & Energy. | |
 Carbon Clean | Carbon Clean operates in Climate & Energy. | |
 Carbon Engineering | Climate & Energy company. | |
 Carbon Health | Healthcare company. | |
 Carbon Maps | Carbon Maps operates in Food & Agriculture. | |
 Carbon Re | Company operating in Climate & Energy. | |
 Carbon Upcycling | Carbon Upcycling operates in Construction. | |
 Carbon-12 Labs | | |
 Carbon3D | | |
 Carbon6 | Company operating in Climate & Energy. | |
 Carbonated | Carbonated Inc. operates in Gaming. | |
 CarbonCure Technologies | CarbonCure Technologies supplies hardware and software that inject captured carbon dioxide into concrete during mixing. The carbon dioxide reacts to form calcium carbonate and becomes permanently embedded, allowing producers to reduce cement use while maintaining concrete performance. Its equipment connects with concrete-plant batching systems, remote telemetry and the myCarbonCure producer platform; the company also generates carbon credits associated with its carbon-utilisation process. | |
 Carbonfact | | |
 Carbyne | Cloud NG911 emergency communications. Formerly Reporty. | New York, New York · Tel Aviv, Israel |
 Cardamon | AI compliance co-pilot for regulated financial businesses. Founded in 2025 by Dmytro Astakhov and Areg Nzsdejan, Cardamon has 11 employees based in London. | |
 CarDash | CarDash operates in Consumer. | |
 Cardino | Founded in 2022, Cardino is the remarketing OS for automotive fleets. It provides end-to-end infrastructure to inspect, price, distribute, and sell fleet vehicles - white-labeled and connected to every channel. Backed by Point Nine, Rosberg Ventures, Sequoia and FJ Labs. | 🇩🇪 · Germany |
 Cardiomatics | Company operating in Healthcare. | |
 CardioRenal Systems | CardioRenal Systems is a medical-device company developing automated fluid-management technology to protect kidney function during high-risk hospital procedures. Its console measures urine output and adjusts physician-prescribed intravenous hydration to replace fluid losses, using disposable infusion and urine-collection sets. The technology is branded RenalPro in the United States and RenalGuard internationally, with development focused on preventing acute kidney injury associated with cardiac surgery and other cardiovascular interventions. CardioRenal Systems, Inc., based in Milford, Massachusetts, is identified in the current operator manual as the manufacturer and parent of RenalGuard Solutions, Inc. The company reports that RenalGuard is CE marked for fluid-balance management outside the United States. RenalPro remains investigational in the United States; the company’s July2026 announcement reports FDA permission to conduct a pivotal cardiac-surgery trial, rather than marketing authorization. | |
 Cardless | Company operating in Fintech. | |
 Cardurion Pharmaceuticals | | |
 careCycle | | |
 Career Karma | | |
 Careerist | Careerist operates in HR & Talent. | |
 CareerTu | | |
 Careforce AI | Careforce AI is a California healthcare software company, legally Helpcare AI, Inc., that builds AI agents for care coordination and administrative workflows. Its Angelica care-coordination agent contacts patients through voice and other channels for scheduling, reminders, referrals, screenings and Medicaid eligibility renewal; its David data agent works across healthcare portals and records to identify patients and coordinate tasks. The software supports health plans, community health centers and other providers, with administrative exceptions and follow-up handled by human staff. Founded in 2024 by CEO Huzaifa Sial, Careforce joined Y Combinator’s Fall 2024 batch. Its current legal footer gives an Alameda address, while its public accelerator and employer profiles identify the San Francisco Bay Area. California Health Care Foundation reports a USD500,000 program-related investment in February 2026 to support care access across the Medi-Cal delivery system. This is distinct from client contracts and adoption metrics. Careforce is relevant to AI agents, healthcare software and workflow automation; it is not represented as an autonomous diagnostic medical device or a neuroscience treatment. The company is distinct from Careforce GmbH, CareForce Cloud and the getcareforce.com clinic-services business. | Alameda, California, United States · San Francisco Bay Area, California, United States |
 Carefull | Carefull operates in Healthcare. | |
 CareLoop Health | CareLoop Health is a University of Manchester spinout developing digital monitoring and relapse prevention for people living with severe mental illness, initially psychosis. Its smartphone app collects daily patient-reported symptoms and offers self-management resources, while predictive algorithms identify changes from an individual baseline and alert care teams. A clinician dashboard supports monitoring, earlier intervention and integration with care pathways. The company works with NHS and research partners to evaluate and deploy its platform, with the aim of keeping people well in their communities and reducing crisis-driven care. Incorporated in 2021, CareLoop raised GBP 1.8 million in seed funding announced in January 2025. | |
 CareLuLu, Inc. | Company operating in E-Commerce & Marketplace. | |
 CAREREV | | |
 Careship | Healthcare company. | |
 Carestack | Carestack operates in Healthcare. | |
 Caretta | | |
 Cargado | Company operating in Logistics & Supply Chain. | |
 Cargo | In-vehicle commerce and last-mile delivery technology for rideshare vehicles. | New York, New York |
 Cargo | | |
 Cargo | | |
 cargo.one | cargo.one is a digital marketplace for booking and marketing air cargo capacity. Founded in 2017, it lets freight forwarders search, compare, and instantly book real-time rates across 60+ airlines, and is trusted by 20,000+ forwarders in 134 countries. | 🇩🇪 · Germany |
 Cargofy | Company operating in Logistics & Supply Chain. | |
 Cariqa | Mobility & Transportation company. | Berlin, DE |
 Carisma Therapeutics | Company operating in Biotech & Life Sciences. | |
 Carl Finance | Company operating in Fintech. | |
 Carlypso | | |
 Carma | Climate & Energy company. | Strawberry Hills, NSW, AU |
 Carmoola | Company operating in Fintech. | |
 CarOnSale | E-Commerce & Marketplace company. | Berlin, DE |
 CarOnSale | | |
 Carousel Technologies | | |
 Carousell Group | | |
 Carrar | | |
 Carrick Therapeutics | | |
 CARRICK THERAPEUTICS LIMITED | | |
 CARROT | Healthcare company. | West Des Moines, IA, USA |
 Carrot Credit | Company operating in Fintech. | |
 Carrot Fertility | Employer fertility benefits including egg freezing and IVF. | |
 Carta | | |
 Cartage | | |
 Cartesia | Cartesia builds low-latency AI models and developer infrastructure for conversational voice applications. Its state-space model architectures power Sonic speech generation, Ink streaming transcription and a managed voice-agent platform. Developers use its APIs and cloud, on-premise or device deployments to build interactive assistants and enterprise calling applications. | San Francisco, California |
 Cartesia AI, Inc. | | |
 Cartesian | Cartesian is a Trondheim energy technology company designing and producing compact thermal batteries for heating and cooling. Its Thermal Box uses phase-change materials to store thermal energy and release it when demand or electricity prices rise. The modular systems integrate with building and industrial heating, ventilation and cooling installations, supporting load shifting and additional thermal capacity. The company commercialises research from SINTEF and NTNU and works with contractors, energy service companies and utilities across Europe. | |
 Carthera | Carthera is a French clinical-stage medical device company developing ultrasound implants to improve delivery of medicines to the brain. Its SonoCloud device temporarily opens the blood-brain barrier using low-intensity ultrasound, and is being studied in brain cancers including glioblastoma and in neurodegenerative diseases. Founded in 2010 as a spin-off from Sorbonne University and AP-HP, the company develops and manufactures its devices and collaborates with clinical research institutions in Europe and the United States. | |
 CarThrottle | Company operating in Media & Entertainment. | |
 Cartken | Cartken operates in Robotics & Automation. | |
 Carto | Carto operates in Data & Analytics. | |
 Cartography Biosciences | Clinical-stage biotechnology company developing antibody-based cancer therapies with selective tumor targeting. Its ATLAS and SUMMIT platforms combine proprietary single-cell datasets, machine learning and computational biology to discover tumor-specific antigens and target combinations, then engineer therapeutic molecules against them. Lead candidate CBI-1214 is a T-cell engager for colorectal cancer in Phase 1 clinical development. The company also collaborates with pharmaceutical partners to discover new oncology targets. | |
 Cartona | Company operating in E-Commerce & Marketplace. | |
 Cartwheel | Cartwheel operates in E-Commerce & Marketplace. | |
 Cartwheel | | |
 Carwale | Company operating in E-Commerce & Marketplace. | |
 Carwoo | | |
 Carwow | Carwow operates in E-Commerce & Marketplace. | |
 Casa | PropTech company. | |
 Casafari | Company operating in PropTech. | |
 Casana | Healthcare company. | Rochester, NY, US |
 CasaOne | | |
 Casap | AI tools for finance operations that automate disputes, chargebacks, and first-party fraud while improving cardholder experience. | New York, New York |
 Casavo | Company operating in PropTech. | |
 Cascade | Enterprise Software company. | |
 Cascade Space | | |
 Cascade Space | | |
 Cascading | | |
 Cascading AI | | |
 Cascala Health | Healthcare company. | |
 Case 45 | Develops AI models for cancer prognosis, treatment selection and drug development using cancer evolutionary biology. | |
 Cased | Developer tools for production environments. | |
 Caseflood.ai | | |
 CaseMark | Legal company. | |
 Casetext | | |
 Cash Flow Portal | | |
 Cashboard | | |
 CashBook | | |
 CashDrop | E-Commerce & Marketplace company. | |
 Cashflo | Fintech company. | |
 Cashfree Payments | | |
 CASHIFY | CASHIFY operates in Fintech. | |
 Cashpresso | Company operating in Fintech. | |
 Caspian | Company operating in Logistics & Supply Chain. | |
 Cassidy AI | AI company. | |
 CAST AI | CAST AI operates in Infrastructure & Cloud. | |
 CAStar | Company operating in Biotech & Life Sciences. | |
 Castelion | Defense manufacturer restoring the U.S. ability to field advanced weapons at speed and scale via rapid iteration, vertical integration, and manufacturing. El Segundo, California. | El Segundo, California |
 Castia | | |
 Castle | Cybersecurity company. | |
 Castle | | |
 Castler | Provides software escrow and recoverability infrastructure for enterprises that depend on third-party software. Its platform holds current source-code deposits, reconstructs and tests software releases independently of the vendor, and produces recovery evidence to support business continuity and technology-risk oversight. It originated as a digital escrow and trust-infrastructure business. | |
 Castore | E-Commerce & Marketplace company. | |
 Cata | Cata operates in E-Commerce & Marketplace. | |
 Catalant | HR & Talent company. | |
 Catalant | | |
 CATALOG | Stores digital data in DNA as a high-density, long-lived archival medium. | Boston, Massachusetts |
 Catalyst | Catalyst operates in SaaS. | |
 Catalyst Therapeutics | Catalyst Therapeutics is an Australian drug-discovery investment and project-management company formed as a joint venture between the Walter and Eliza Hall Institute of Medical Research and SYNthesis Research. It supports early translational research through chemical screening, medicinal chemistry, proof-of-concept funding and partnering or licensing. Its published projects include selective BET bromodomain inhibitors for cancer and inflammatory disease, a pseudokinase screening platform, and computational drug design combining AI, machine learning, molecular dynamics and quantum chemistry. Its wholly owned operating subsidiary, Anaxis Pharma, develops small molecules that modulate inflammatory cell death. Catalyst’s programs are research and drug-development projects; computational modelling is not quantum-computer hardware, and a licensing agreement does not imply medicine approval. | Parkville, Melbourne, Victoria, Australia |
 Catawiki | Catawiki operates in E-Commerce & Marketplace. | |
 catch + release | catch + release operates in Media & Entertainment. | |
 Catch Co | Company operating in E-Commerce & Marketplace. | |
 Catena Labs | Fintech company. | |
 Cato Networks | | |
 Caucell | Accessible omics laboratory platform. | |
 Cauldron | Cauldron operates in Gaming. | |
 Causa Prima | Fintech company. | Madrid, ES · Munich, DE |
 Causal | Causal operates in Data & Analytics. | |
 Causal Labs | Causal Labs operates in AI. | |
 causaLens | Company operating in AI. | |
 Causaly | Company operating in Biotech & Life Sciences. | |
 Cavalry Biosciences | Cavalry Biosciences develops medicines that direct the regenerative effects of insulin-like growth factor 1 (IGF-1) to specific tissues. Its antibody-biologic conjugate platform combines engineered IGF-1 with tissue-targeting antibodies. Investigational programmes include CAV-011 for corneal regeneration, CAV-033 for skeletal muscle and CAV-044 targeting Schwann cells to promote remyelination in peripheral neuropathies. | |
 Cavelo | Company operating in Cybersecurity. | |
 Caya | Provides document processing and workflow software that helps small businesses digitize and automate administrative work. | |
 Cazoo | E-Commerce & Marketplace company. | |
 cData | cData operates in Data & Analytics. | |
 Ceartas | Ceartas operates in Legal. | |
 Cedalio | | |
 Cedana | | |
 Cedar | Cedar operates in Logistics & Supply Chain. | |
 Cedar | | |
 Ceezer | Company operating in Climate & Energy. | |
 Ceibo | Company operating in Climate & Energy. | |
 Cekura | Enterprise Software company. | |
 Cekura Ai | Cekura provides automated testing, observability, monitoring, and red-teaming tools for voice and chat AI agents. | |
 Celadyne Technologies | Company operating in Climate & Energy. | |
 Celeno Communications | | |
 Celequest | | |
 Celequest | | |
 Celery | | |
 Celestia Labs | Celestia Labs is a core contributor to Celestia, a modular blockchain network that separates consensus and data availability from execution so developers can deploy customizable blockchains. | |
 Cellares | Cellares operates in Biotech & Life Sciences. | |
 Cellbyte | AI agents for pharmaceutical drug launches, pricing and reimbursement workflows. | |
 CellChorus | Provides dynamic single-cell analysis for drug discovery and cell-therapy development. Its TIMING platform combines time-lapse imaging and visual AI to measure cell movement, activation, interactions and killing over time, helping researchers evaluate immune-cell function and therapeutic candidates. | |
 Cellestial Health | Cambridge neuroscience biotechnology spinout developing small-molecule medicines that protect astrocyte networks in the brain. Its preclinical pipeline seeks to slow Parkinson’s disease progression and address both motor and non-motor symptoms, with potential applications in other neurological disorders. The company targets several molecular mechanisms in astrocytes, a type of brain cell involved in maintaining neuronal function. It uses brain-penetrant compounds and translational drug discovery to develop disease-modifying treatments, rather than only symptomatic therapies. | |
 CellFE | Company operating in Biotech & Life Sciences. | |
 CelLink | CelLink operates in Hardware & Semiconductors. | |
 Cellino | Cellino operates in Biotech & Life Sciences. | |
 Cello | Company operating in SaaS. | |
 Cellular Intelligence | We are building a future where biology is no longer destiny, but design. | |
 Cellvoyant | An AI-first biotech company building platforms for predictive cell analytics and delivering process optimisation services | |
 Celona | | |
 Celonis | Celonis operates in Data & Analytics. | |
 Celus | AI company. | |
 Cemit | Cemit is a Norwegian railway technology company combining onboard sensors, cloud software and AI to monitor the condition of tracks, trains and trams. Its sensors collect vibration data during normal operation and transmit it to the CEMIT Railway Intelligence Platform, which helps operators detect deterioration, investigate changes, schedule maintenance and improve passenger comfort. The platform provides separate insights into infrastructure health and vehicle performance, supporting safer and more efficient railway operations. | |
 Census | Census operates in Data & Analytics. | |
 Censys | Cybersecurity company. | |
 Centaur | Centaur operates in AI. | |
 Centaur Analytics | | |
 Centaur Labs | Centaur Labs operates in AI. | |
 Centivax | Centivax operates in Biotech & Life Sciences. | |
 Centivo | Centivo operates in Healthcare. | |
 CentML | AI company. | |
 Central | Social & Community company. | |
 CentralComs | | |
 Centralize | | |
 Cents | | |
 Cephable | AI company. | |
 Cequence | Cequence enables organizations to realize the promise of AI while defending their applications and APIs from attacks, abuse, and fraud. | Santa Clara, CA, US |
 Cerby | Security for nonstandard applications. | |
 Cercli | Cercli operates in HR & Talent. | |
 Cerebras | Cerebras operates in Hardware & Semiconductors. | |
 Cerebras Systems | Cerebras Systems operates in AI. | |
 Cerebrium AI | AI company. | |
 Cerenion | Cerenion is a Finnish medical-device company developing AI-assisted monitoring of brain activity for acute healthcare. Its C-Trend EEG Station combines a disposable electrode array, EEG amplifier and quantitative analysis software to record brain electrical activity and display continuous trends for clinicians. The software measures slow-wave activity, burst suppression, amplitude-integrated EEG and alpha-delta ratios, helping intensive-care teams review changes in brain function alongside the original EEG recordings. The system is designed to make continuous EEG monitoring accessible to doctors and nurses who are not EEG specialists; the software does not itself provide diagnostic conclusions. | |
 Ceretype Neuromedicine | Cambridge, Massachusetts neuroscience technology company providing functional MRI services, analysis software and brain-circuit insights for drug and device developers. Its cloud platform processes fMRI scans using specialized acquisition and artifact-correction methods to measure brain activity and connectivity across patients, scanners and clinical sites. It produces Brain Insight Reports and biomarkers that help researchers characterize disease subtypes, measure treatment effects and assess which neural circuits a therapy affects. Initial applications include mood and anxiety disorders and neurodegenerative disease. Founded by physician-scientists with psychiatric neuroimaging expertise, Ceretype also develops future clinical decision-support applications, which remain under development. | |
 Cerevance | Cerevance is a private neuroscience drug discovery and development company with operations in Boston, Massachusetts and Cambridge, United Kingdom. Its NETSseq platform measures transcriptional and epigenetic differences in specific human brain cell types. The company combines more than 16,000 human brain tissue samples with advanced machine learning to identify drug targets for neurodegenerative, psychiatric and CNS-controlled metabolic diseases. Its lead candidate solengepras (CVN424) is an investigational oral GPR6 inverse agonist for Parkinson’s disease. On October 7, 2026, Cerevance reported positive Phase 3 ARISE results, including achievement of the primary endpoint, and plans to discuss a potential New Drug Application with the FDA. The medicine remains investigational. Cerevance launched in December 2016 with a Takeda research team, licensed drug programs and laboratory resources and Series A equity backing from Takeda and Lightstone. It also collaborates with Merck on Alzheimer’s disease target discovery and program licensing. Its USD20 million Series C, announced in May 2026, supports clinical development and the company’s broader neuroscience pipeline. | Boston, Massachusetts, United States · Cambridge, United Kingdom |
 Cerevasc | | |
 CereVasc, Inc. | | |
 Cerevel Therapeutics | Cerevel Therapeutics was a clinical-stage biotechnology company developing therapies for neurological and psychiatric diseases; AbbVie completed its acquisition in August 2024. | |
 Ceribell | Medical-technology company developing point-of-care EEG systems for rapid diagnosis and continuous neurological monitoring in acute-care settings. Its portable hardware is combined with AI algorithms for suspected seizure detection in intensive-care units and emergency departments. Headquartered in Sunnyvale, California. | Sunnyvale, California |
 Cernel | Cernel is an Aarhus software company building AI infrastructure for ecommerce product data. Its platform imports raw supplier information, structures product attributes and categories, enriches missing information, and produces multilingual descriptions, imagery and listings for different sales channels. It connects to retailers’ product-information systems and stores, synchronises catalogues in both directions and shows the reasoning and sources behind AI-generated changes so people can review results and provide feedback. Retailers and brands use it to automate product onboarding at scale, maintain consistent catalogues and prepare products for discovery by AI shopping assistants. | |
 Cerrion | Cerrion operates in Enterprise Software. | |
 Certainly Health | | |
 Certific | Company operating in Cybersecurity. | |
 Certifier | Company operating in Enterprise Software. | |
 Certify | Fintech company. | |
 Certify OS | Healthcare company. | |
 Certik | | |
 Certn | Company operating in HR & Talent. | |
 Certus AI | Voice-AI company developing telephone agents for restaurant orders, reservations and catering inquiries, with point-of-sale integrations. | |
 Cerula Care | Cerula Care operates in Healthcare. | |
 Cervest | Cervest developed climate-intelligence software that helped organizations understand physical climate risks to buildings and other assets. Its EarthScan platform combined climate science and data analysis to support risk management and adaptation planning. | |
 CesiumAstro | Builds satellites, communications terminals and software-defined phased-array systems for commercial, government and defence missions in space, air and on the ground. | |
 CFS- | Some news that's fit to print in the <a href="https://www.nytimes.com/2020/09/29/climate/nuclear-fusion-reactor.html" rel="noreferrer nofollow">NYT</a> today: <i> Compact Nuclear Fusion Reactor Is Very Likely to Work, Studies Suggest</i> TLDR; "in seven peer-reviewed papers published Tuesday in a special issue of <a href="https://www.cambridge.org/core/journals/journal-of-plasma-physics/collections/status-of-the-sparc-physics-basis" rel="noreferrer nofollow">The Journal of Plasma Physics</a>, researchers laid out the evidence that SPARC would succeed and produce as much as 10 times the energy it consumes." "Scientists developing a compact version of a nuclear fusion reactor have shown in a series of research papers that it should work, renewing hopes that the long- | |
 CH4 Global | Climate & Energy company. | |
 Chai | Consumer character-chatbot platform (Chai AI). Founded in Cambridge, relocated to Palo Alto. | Palo Alto, California |
 Chai Discovery | Healthcare company. | |
 Chain | Company operating in Crypto & Web3. | |
 Chainalysis | Founded in 2014, Chainalysis maps blockchain activity to real‑world entities so organizations can detect and prevent crypto crime, recover funds, and meet AML requirements. Its investigation, risk, and compliance products are trusted by law enforcement, regulators, and exchanges globally. | 🇺🇸 · USA |
 Chainguard | Secure-by-default open-source software library and container images. Helps organizations start left with security. Customers include Snowflake, Canva, and HPE. | Kirkland, Washington |
 Chainguard Dev | | |
 Chainlink | Chainlink is a decentralized oracle platform that connects smart contracts with external data, systems, and cross-chain services. | |
 Chaka | | |
 Chaldal | | |
 Chalk | Education company. | San Francisco, CA, US |
 Chalk.ai | | |
 Chamber | Infrastructure & Cloud company. | |
 Chamber Cardio | Healthcare company. | |
 Chamelio | Company operating in Legal. | |
 Change | | |
 Change.org | | |
 Changingedu | | |
 Chango | | |
 Channel3 | | |
 ChannelEngine | ChannelEngine operates in E-Commerce & Marketplace. | |
 CHAOS | Chaos operates in Defense & Space. | |
 Chaos Genius | | |
 Chaos Labs | On-chain economic security and risk platform using EVM simulations. Used by Aave, GMX, dYdX and other DeFi protocols. | Tel Aviv, Israel · New York, New York |
 Character Biosciences | Character Biosciences develops precision medicines for progressive polygenic diseases, initially focusing on age-related macular degeneration and primary open-angle glaucoma. It combines human genetics, longitudinal clinical data, retinal imaging and AI-driven modeling to identify disease subtypes, discover therapeutic targets and select patients for clinical trials. Its pipeline includes CTX114, a complement inhibitor for geographic atrophy, and CTX203, a lipid modulator intended to prevent progression to advanced age-related macular degeneration. | |
 Character.ai | Personalized AI companions on a proprietary LLM. Founded 2019. Menlo Park / Palo Alto. | Menlo Park, California |
 Charco Neurotech | Charco Neurotech operates in Healthcare. | |
 Chargebee | Brightback built no-code retention automation for subscription businesses, helping brands test cancellation alternatives such as offers, pauses and downgrades; Chargebee acquired it in 2022. | |
 ChargeLab | Company operating in Climate & Energy. | |
 Chari.ma | Chari.ma is a Moroccan financial super-app offering an e-wallet with an IBAN, Visa cards, transfers, bill payment, mobile top-ups, and merchant payments. | |
 Chariot Defense | Defense & Space company. | |
 Charles River Laboratories | Charles River Laboratories is a publicly listed life-sciences research and development services company founded in 1947 and headquartered in Wilmington, Massachusetts. It supports pharmaceutical, biotechnology and academic customers with research models, drug discovery, preclinical safety assessment and manufacturing services. Its neuroscience capabilities include central nervous system discovery services. With Valo Health, it developed Logica, an AI-powered drug-discovery offering, and it made an equity investment in causal AI and digital-twin company Aitia in November 2023. Birgit Girshick became CEO in May 2026; James C. Foster retired from executive leadership and remains a director. Charles River also makes strategic biotechnology investments; recorded investment links reflect verified financing disclosures and are being expanded through portfolio research. | |
 Charles.co | Company operating in Healthcare. | |
 Charm Industrial | Climate & Energy company. | San Francisco, CA, US |
 Charm Therapeutics | Biotech & Life Sciences company. | |
 Charta | | |
 Charta Health | | |
 ChartMogul | ChartMogul is a subscription analytics platform that unifies billing data to track key SaaS metrics like MRR, churn, LTV, and cohorts, helping thousands of subscription businesses worldwide measure and grow their recurring revenue. | 🇩🇪 · Germany |
 Chatous | Social & Community company. | |
 Chatterbug | Whatever your current level, learn languages through adaptive courses and one-on-one video sessions with native speakers. Try it out free for 14 days. | San Francisco, CA, USA |
 Chatwoot | | |
 Che300 | | |
 Checkerspot | Develops microalgal strains and precision-fermentation processes to manufacture high-value fats, oils and materials. Its current focus is supplying food, nutrition and wellness partners with differentiated lipid ingredients, including nutritional oils, bioactive fatty acids and alternatives to tropical fats; its technology has also been used in performance materials. | |
 Checkly | Checkly operates in Developer Tools. | Boston, MA, US |
 Checkr | | |
 Checkr Com | Checkr Com operates in HR & Talent. | |
 CheckSammy | Provides waste removal, recycling and sustainability services, using software and data to coordinate commercial waste logistics and track materials. | |
 Cheddar | | |
 Cheetah | E-Commerce & Marketplace company. | |
 Chef | Developer Tools company. | |
 Chef Robotics | AI-enabled food-prep robotics company. | |
 ChefHero | | |
 ChefSteps | Seattle cooking-education company that publishes recipes, guides and classes and developed the Joule sous vide device. Founded in 2012 at Pike Place Market by chefs from Nathan Myhrvold's Modernist Cuisine team, including Chris Young and Grant Crilly. Acquired by Breville on 16 July 2019. | Seattle |
 ChemFinity | Brooklyn company building sorbent filters to recover critical minerals from domestic waste streams. Spun out of UC Berkeley. | New York, New York |
 Chemix | Company operating in Climate & Energy. | |
 CheqUPI | | |
 Cherry | Payment automation. | |
 Cherry Recommends | | |
 Chewse | Company operating in Food & Agriculture. | |
 ChicChickClub | ChicChickClub was a Berlin-based subscription commerce service for women’s shoes, bags, and accessories. It offered monthly personalized selections via a style quiz, aiming to be Germany’s leading shoe-shopping club with a monthly subscription model. | 🇩🇪 · Germany |
 Chief | Chief operates in HR & Talent. | |
 Chief | | |
 Chift | Developer Tools company. | |
 Chili Piper | SaaS company. | |
 Chilibeli | Chilibeli was an Indonesian community-based social-commerce platform that connected households and community agents with fresh produce and daily necessities. | |
 Chillr | | |
 ChipAgents | Develops AI agents that help semiconductor engineers design and verify chips, automating analysis and repetitive work in electronic-design workflows. | |
 Chiral | Chiral Nano — nanomaterials company. | |
 Chirply | | |
 Chitmonks | Provides blockchain-based software for digitizing chit fund operations, transactions and administration. | |
 Chkk | | |
 Chloris Geospatial | Climate & Energy company. | |
 Choco | Choco operates in Food & Agriculture. | |
 Chord | Media & Entertainment company. | |
 Chowbus | Chowbus operates in Food & Agriculture. | |
 Chowdeck | | |
 Chr. Augustinus Fabrikker | Chr. Augustinus Fabrikker Aktieselskab is a Copenhagen-based Danish investment holding company, CVR21411914, wholly owned by Augustinus Fonden. Its historical business origins date to1750; the philanthropic foundation is a separate legal institution. The company invests its own capital, combining long-term ownership of established Danish businesses, direct scale-up equity investments and financial investments in listed/unlisted securities and externally managed private-equity, venture and impact funds. Its scale strategy backs companies with Danish roots, demonstrated commercial activity and international ambitions. Relevant holdings include healthcare AI developer Corti, digital-health software company DawnHealth, climate/energy technology company Stiesdal, AI sports-camera company VeoTechnologies and laboratory cold-chain monitoring company Eupry. Sector activity does not establish regulatory clearance or clinical efficacy of portfolio products. Its own portfolio and announcements confirm first Corti investment inSeptember2021 and follow-on participation inSeptember2023, with source-qualified institutional transactions recorded separately from personal investors. CEO ClausGregersen leads the current organisation, whose own public directory contains13 investment-team members,9 secretariat/finance staff,1CEO and7 board members. The investment holding company is distinct from employment and grantmaking by its parent foundation, even where directors are shared. Its published DKK2billion scale allocation is internal investment capacity, not an external LP fund close, a company financing round, or the amount of any individual portfolio check. No balance-sheet asset valuation, equity holding percentage, tobacco-company history or externally managed fund subscription is presented as capital newly raised by this profile. | Copenhagen, Denmark |
 Chroma Medicine | Biotech & Life Sciences company. | |
 Chronicle | Chronicle operates in SaaS. | |
 ChronicleBio | US biotechnology company developing an AI and multi-omics platform to discover treatments for complex chronic and neuroimmune conditions. It combines longitudinal clinical information and biological samples from its Chronicle Biobank with large biological models to identify disease mechanisms, distinguish patient subgroups and guide therapeutic development. Its work aims to translate human biological data into targeted medicines; it remains a research and drug-discovery platform rather than an approved treatment provider. | |
 Chrono24 | Chrono24 operates in E-Commerce & Marketplace. | |
 Chronosphere | Cloud-native observability. Backed by Founders Fund among others. | New York, New York |
 Chute | | |
 Cibando | Cibando was an Italy-based, mobile-first restaurant search and discovery service. It was known for professionally curated photos and editorial reviews, helping diners find top dining spots across Italy. The company was acquired by Zomato in 2014, with the team leading Zomato’s expansion in the Italian market. | 🇮🇹 · Italy |
 CIC Ouest | Banque CIC Ouest (CIC Ouest) is the French regional commercial bank registered as a société anonyme under SIREN 855801072, RCS Nantes, ORIAS 07008480. Its headquarters are at 2 avenue Jean-Claude Bonduelle in Nantes. It serves households, professionals, private-banking clients and businesses across 22 departments of western and central France. CIC Ouest belongs to the CIC/Crédit Mutuel Alliance Fédérale banking network, but is a separate legal counterparty from Paris-based Crédit Industriel et Commercial, Crédit Mutuel Equity, Crédit Mutuel Asset Management and CIC Private Debt. It supplies corporate credit and innovation finance rather than operating an independent external LP venture fund. Neuroscience relevance includes the exact EUR 650,000 state-guaranteed loan obtained by stroke-treatment biotechnology company Acticor Biotech in early July 2020; the state guarantee does not substitute the government as the cash lender and the exact loan day is undisclosed. Laurent Berger has chaired CIC Ouest since April 23, 2025 and Mireille Haby is its current CEO. Public natural-person governance is recorded using the September 2026 French register and more recent issuer legal notices, including Jacques Barillet’s September 9, 2026 resignation and Laurence Carde’s representative seat for corporate director CIC. Five other executive-committee roles are explicitly qualified as published in the bank’s own 2024 regional booklet, rather than presumed current. The public roster covers named governance and the latest located published management committee, not the bank’s2,300-plus entire workforce or the separate CIC parent board. Eight legal-entity directors and two corporate audit firms remain distinguished from individual team members. Its registered share capital of EUR 86,998,832 is not presented as a fundraising event. Deposits, credit balances, group-level investment allocations, external asset-manager products and startup-award recognition are not counted as newly raised LP funds or inferred portfolio equity checks. | Nantes, France |
 Cidara Therapeutics | | |
 Cien | AI company. | |
 Ciena | | |
 Cifrato | | |
 Cilcare | Cilcare is a French biotechnology company founded by Celia Belline, Sylvie Pucheu and Marie-Pierre Pasdelou to develop treatments and research technologies for auditory disorders. Its active French SAS was legally created on June 6, 2014 (SIREN 803146125; VAT FR00803146125). Based in Montpellier with operations in the Boston area and additional offices named in Paris and Tokyo, Cilcare studies cochlear synaptopathy, hearing loss, tinnitus and related conditions. It combines investigational drug candidates CIL001 and CIL003, preclinical research services and an Auditory Analytics platform using artificial intelligence and machine learning to characterize hearing function, identify biomarkers and support clinical-study patient selection. Observational studies in diabetes and neurodegenerative disease populations remain research activities; the company has not established a dementia treatment. Its public directory names 46 employees and 12 scientific advisers. An April 18, 2024 announcement confirmed an undisclosed capital infusion involving the University of Vermont Health Network, ARIS, Sofilaro and Sud PME Croissance. On December 4, 2024, Cilcare announced a EUR40 million Series A aggregate that included EUR21 million in its latest financing, naming Shionogi and SPRIM Global Investments as new investors alongside existing shareholders. Its 2017 financing included a verified EUR240,000 Sofilaro investment; the overall amount was described as more than EUR650,000. Research support includes a June 2024 EUR4.2 million France2030 i-Démo award with 40% grant support and a May 2026 FEDER project with support of up to EUR0.6 million over three years. A June 2026 Sanofi license amendment exchanged improved royalty terms for minority equity; no cash investment amount was disclosed. | Montpellier, France · Boston, Massachusetts, United States · Paris, France · Tokyo, Japan |
 Cimulate | Company operating in E-Commerce & Marketplace. | |
 Cinapse | | |
 Cinder | Cinder operates in Cybersecurity. | |
 Cino | Cino operates in Fintech. | |
 Cint | Cint provides research and measurement technology, including a programmatic marketplace that connects researchers and advertisers with survey respondents worldwide. | |
 Cintoo | Company operating in PropTech. | |
 Cionic | Cionic develops wearable neurotechnology to help people with neurological mobility impairments walk. Its Neural Sleeve combines motion and muscle sensors, adaptive AI and functional electrical stimulation in a garment that analyzes movement and adjusts muscle stimulation in real time. A companion app and mobility specialists support personalized training. The company serves people with conditions such as multiple sclerosis, stroke and cerebral palsy and develops research tools for clinicians studying movement. | |
 CipherOwl | Crypto & Web3 company. | |
 Circle | Circle operates in Crypto & Web3. | |
 Circleback | | |
 CircleBack | | |
 Circuit & Chisel | Company operating in Hardware & Semiconductors. | |
 CircuitLab | | |
 Circuitry.ai | Circuitry.ai develops Service Decision Intelligence software for manufacturers of complex products and equipment. Its platform uses generative, predictive and agentic AI, service knowledge graphs and domain-specific decision models to help teams answer product questions, troubleshoot repairs, identify parts and process warranty or service-contract claims. Its enterprise AI-as-a-Service products include Product Advisor, Service Advisor, Parts Advisor and Warranty Decision Intelligence, with AI advisors, analysts, agents and workers supporting service operations. The company serves industrial machinery, automotive, heavy equipment, electronics, imaging equipment and medical-device service organisations. These are enterprise service/support tools, not established clinical diagnostic devices or neuroscience therapies. Product accuracy, ROI and deployment-speed percentages on its website are vendor claims, not independent clinical validation. Commercial customer/partner announcements are separate from equity investment or acquisition cash.
Identity reviewed October8,2026: exact own domain circuitry.ai and self-published corporate LinkedIn identify a private company founded2023, with Tampa headquarters and an AI R&D operation in Hyderabad. Its own privacy policy/website terms identify the business as Circuitry.ai; the precise underlying legal corporation name, registry identifier and incorporation day are not proven in the reviewed primary disclosures, so similarly worded secondary Inc. names are not substituted or cloned. Native/SQL name and domain preflights found no exact company record, only references in two existing managers. Founder and CEO AshokKartham previously founded Mize and4CS; those former companies are distinct, and his historic exits are not Circuitry.ai fundraising. Its October2024 Hyderabad R&D expansion is an operating investment, not a separately priced equity round.
Full public named scope comprises18 people: five website leadership members AshokKartham, PaulCunningham, TedDanner, JoshRussell and NaveenSrinivas;2026 own-event employees NickHall, DhruvDesai and BobJuno; public company-directory employees RodLangohr, SudhirSingh, BalajiSridharG and SatyaPrasadPV; source-scoped advisers LorienPratt and MarkHessinger; seed-board appointee BenPatz; and dated2024/2025 staff DheerajInampudi, NathanTarpey and MikeWoellert. Paul is published as a growth/transformation leader and five-time historical CRO, not asserted to be the current company CRO. Mark’s role is scoped to its AI advisory-lab programme. Lorien’s appointment is explicitly announced February19,2024, with current continuation not independently confirmed; Ben’s board appointment was announced in the2025 seed release and is similarly time-qualified. Historical engineering/product/marketing titles are not presented as independently verified current employment. Sudhir’s own profile explicitly identifies VP of Platform Engineering; Balaji’s identifies Product Designer; Satya’s issuer job listing identifies HRBPManager. Rod’s exact current rank remains unpublished. The employer-directory and own event staff listings do not establish a complete privately employed workforce. Fifteen authentic new individually associated portraits are verified, with Ben’s existing authentic DeepWork portrait preserved; authentic Nathan/Mike portraits remain gaps. Dheeraj’s current personal website identifies work building EigenH AI, supporting explicit historical qualification of his Circuitry engineering affiliation; exact departure date is unpublished. NickHall’s existing namesake at GundersonDettmer is a different person and is preserved; the company employee has a separate qualified identity and genuine own portrait. External customer/guest speakers are excluded from company staff.
Actual financing: one seed round was explicitly reported closed October1,2025, led by DeepWorkCapital with FloridaOpportunityFund, Lasagna and LookoutVentures participating. Total equity cash, valuation, individual tickets, subscribing legal vehicles and exact closing/payment day are undisclosed. The structured round amount and individual tickets stayNULL; October1 is the announcement day, not an assumed disbursement day. The institutional participants are source-qualified at the published manager or institution level, with exact subscribing-fund allocations unproved. FloridaOpportunityFund is separately governed from its adviser DeepWorkCapital; its company investment is not attributed to the manager’s own capital. LookoutVentures is distinct from the similarly named cybersecurity company. No prior/second financing, government grant, founder personal check or acquisition proceeds are inferred without primary transaction proof. | 15310 Amberly Drive, Suite 250, Tampa, Florida 33647, United States · IndiQube Pearl, MindSpace Road, Hyderabad, Telangana 500032, India |
 Circular | Circular was a hiring network where in-house recruiters shared pre-vetted candidates they couldn’t hire, helping tech companies fill roles faster with warm referrals. | 🇪🇸 · Spain |
 Circular | | |
 Circular Genomics | Circular Genomics develops blood-based circular RNA biomarkers and analytical tools for research into neurological and psychiatric disorders. Its CircPath platform profiles brain-derived circRNAs to investigate disease pathways, identify biomarkers and characterize patient cohorts. Published applications include Discover 1600+ for broad circRNA profiling, AD Detect for research into biomarker-defined Alzheimer’s disease biology, and AD Predict for research into future cognitive impairment and symptom progression. The current CircPath applications are labelled for research use only and are not intended for diagnostic procedures. The company also announced the historical launch of MindLight in September 2024, a blood assay intended to help clinicians assess antidepressant response in major depressive disorder; its present availability is unverified. Circular Genomics works with academic and biopharma partners on biomarker validation and licensed intellectual property, with headquarters at Lilly Gateway Labs in San Diego. | San Diego, California, United States |
 Circularity Fuels | Climate & Energy company. | |
 Circulate Health | Company operating in Healthcare. | |
 Circulor | Company operating in Logistics & Supply Chain. | |
 Circumvent | | |
 Ciridae | We are Ciridae. The AI Transformation Firm | |
 CirqlOne | AI company. | Heidelberg, Baden Wurttemburg, DE |
 Cisco Systems | | |
 CisLunar | | |
 Citadel | | |
 Citadel Securities | | |
 Citcon | Company operating in Fintech. | |
 Citizen | Citizen operates in Social & Community. | |
 Citizen Health | Citizen Health operates in Healthcare. | |
 Citrea | Bitcoin ZK rollup. $14M Series A. | |
 Citrine Informatics | Company operating in Data & Analytics. | |
 Citus Data | Company operating in Data & Analytics. | |
 City Therapeutics | Develops RNA interference medicines using engineered small interfering RNAs to silence disease-related genes. Its pipeline includes programs targeting Factor XI for thromboembolic disease, RBP4 for Stargardt disease and TFR2 for anemia of chronic disease, alongside technology intended to extend RNAi medicines to additional tissues and therapeutic areas. | |
 Cityblock Health | Healthcare company. | |
 Citymall | Citymall operates in E-Commerce & Marketplace. | Gurgaon, Haryana, IN |
 Citymapper | Citymapper operates in Mobility & Transportation. | |
 Civic Marketplace | Local government procurement platform | US |
 Civio | Builds AI software for companies selling to government, connecting customer signals, internal systems and stakeholders to coordinate sales and growth workflows. | |
 Civitai | Civitai operates in Social & Community. | |
 Civitas Learning | Education company. | |
 Clad Labs | | |
 Claim | | |
 Claim Health | | |
 Claimer | Company operating in SaaS. | |
 claimsforce | claimsforce is a Hamburg-based insurtech providing a SaaS platform for end-to-end claims management. It builds modern claims software for P&C insurers and loss adjusters, offering modular tools to digitize and automate processes, improving cycle times and customer experience across DACH and the UK. | 🇩🇪 · Germany |
 ClaimSorted | ClaimSorted operates in Fintech. | |
 Claimwise | Developed AI tools for patent search, claim analysis and European patent workflows. Acquired by Solve Intelligence in 2026. | |
 Clair | Company operating in Fintech. | |
 Clair Health | Clair Health, Inc. is developing an AI-assisted wearable and companion app for women’s hormone and cycle insights. Its wrist device combines physiological sensors with machine-learning models trained on paired wearable and hormone-test data to infer hormonal patterns from cardiovascular, autonomic and temperature signals, rather than directly measuring hormones in blood or urine. Its research describes a Female Biology World Model informed by hypothalamic–pituitary–ovarian neuroendocrine dynamics. Clair 1.0 is described as a general wellness product; quantitative hormone reporting and FDA clearance are future goals for a later product. Company-reported early performance metrics are not treated as independent clinical validation or approval. Co-founders Jenny Duan and Abhinav Agarwal lead the company, with publicly named medical and research advisors. The CEO’s current professional profile places the growing team in Menlo Park, California; its June2026 financing announcement described it as San Francisco-based. As reviewed October7,2026, the company website expects founding-member shipments in December2026, so commercial delivery is still prospective. Transaction counsel confirms a USD11.6M seed round announced June17,2026, led by Khosla Ventures. A separate earlier founder announcement identifies an undisclosed pre-seed round led by a16z SPEEDRUN and Reach Capital. Mayo Clinic Platform named Clair among the inaugural participants of its multiyear Accelerate pathway on September3,2026, supporting research and model validation with clinical data and expertise. Program participation is not evidence of completed validation, FDA clearance, or a Mayo financial investment. | Menlo Park, California, United States |
 Clairvolex | Clairvolex operates in Legal. | |
 Clara | Fintech company. | |
 Clara | | |
 Clara | | |
 Clara | | |
 Clara Labs | AI company. | |
 Clarabridge | | |
 Clari | | |
 Clarifai | Company operating in AI. | |
 Clarified Precision Medicine | Clarified Precision Medicine combines an AI and machine-learning platform with a medical group to help oncologists interpret genomic test results and select personalized cancer treatments. Its asynchronous molecular tumor board provides expert-reviewed, guideline-based therapy options from a patient’s tumor profile. ClarifiedSelect supports treatment guidance; OncoGuardian provides pharmacogenomics and gene-to-drug risk guidance; ClarifiedData supports oncology data analysis and discovery. The company also helps institutions build and sustain their own precision medicine tumor boards. It serves oncology providers, payers, testing laboratories and life-science organizations, with medical experts reviewing recommendations before they are used in clinical workflows. | San Francisco, California, United States |
 Clarify | SaaS company. | Seattle, WA, US |
 Clarity | Clarity operates in AI. | |
 Clarity Movement | Clarity Movement provides air-quality monitoring hardware, software and services. Its connected sensor networks help governments, communities and businesses measure pollution and understand local air conditions. | |
 Clarity Value | | |
 Clarium | Fintech company. | |
 Clark | Company operating in Insurance. | |
 Clarke | Clarke operates in Fintech. | |
 Claros | Hardware & Semiconductors company. | |
 ClassDojo | Education company. | |
 Classiq | Company operating in Hardware & Semiconductors. | |
 ClassPass | Consumer company. | |
 Classplus | Company operating in Education. | |
 Classtag | Education company. | |
 Clausematch | Company operating in Legal. | |
 Clay | Clay operates in SaaS. | |
 Clazar | Company operating in Enterprise Software. | |
 CleanCo | | |
 Cleancult | Cleancult operates in Consumer. | |
 CleanHub | CleanHub operates in Climate & Energy. | |
 Clear | | |
 Clear Labs | Biotech & Life Sciences company. | |
 Clearco | Revenue-based financing, formerly Clearbanc. | Toronto, Canada |
 ClearFeed | ClearFeed operates in SaaS. | |
 Clearglass | Company operating in Enterprise Software. | |
 Clearly | Software for businesses and financial institutions transitioning fleets to net-zero emissions. | |
 Clearmetal | Company operating in Logistics & Supply Chain. | |
 CLEARMIX | | |
 Clearpath | | |
 Clearpath Robotics | Robotics & Automation company. | |
 ClearSky Data | | |
 ClearSpace | Company operating in Defense & Space. | |
 Clearstory Data | Company operating in Data & Analytics. | |
 ClearTrust | Provides ad-fraud detection and traffic-quality analysis for advertisers, publishers and advertising platforms. Its software analyzes clicks, impressions, sessions and leads for bots and other invalid activity, scores traffic quality, and helps customers monitor and filter fraudulent digital advertising traffic. Previously known as Botman. | |
 Cleave Biosciences | Company operating in Biotech & Life Sciences. | |
 Cledara | Company operating in Fintech. | |
 Clee Medical | Swiss neurotechnology company developing Neuro Access, an intraoperative brain-imaging platform combining optical coherence tomography, navigation and AI-supported guidance. A minimally invasive probe aims to help surgeons visualize tissue and blood vessels during stereotactic procedures. The system is undergoing product development, clinical validation and regulatory preparation. | Geneva, Switzerland |
 Cleerly | Cleerly is a Denver-based medical imaging AI company founded in 2017 by cardiovascular imaging researcher James K. Min. Its platform analyzes coronary CT angiography to quantify and visualize plaque, stenosis and likely vessel-level ischemia, helping clinicians evaluate coronary artery disease. Products include Cleerly Labs, Plaque, ISCHEMIA and COMPARE. FDA records show LABS K260588 and the separate Plaque add-on K261210 received 510(k) clearance on July 29, 2026. Plaque’s outputs support trained clinicians’ assessment and do not constitute a final diagnostic report. Cleerly ISCHEMIA received FDA 510(k) clearance K231335 on September 8, 2023 as a prescription adjunct for clinically stable symptomatic patients undergoing cardiac CT; clinicians must interpret its findings, and patient management must not rely solely on the result. The investigational CAD Staging System received Breakthrough Device Designation in March 2024, which is distinct from marketing clearance. Verified announced financings include a $43 million Series B in June 2021, a July 2022 Series C updated from $192 million to $223 million, and a $106 million Series C extension in December 2024 led by Insight Partners. Earlier cumulative financing figures are not represented as additional disclosed rounds. | Denver, Colorado, United States |
 Clene | Clene Inc. (Nasdaq: CLNN) is a clinical-stage neuroscience and nanomedicine company developing catalytically active gold nanocrystals to improve cellular energy metabolism and neuronal function. Its wholly owned Clene Nanomedicine subsidiary develops CNM-Au8, an investigational oral suspension studied in ALS, multiple sclerosis and Parkinson’s disease. As of the September 2026 issuer update, an ALS NDA under the accelerated approval pathway was planned; FDA acceptance and marketing approval had not been announced. A future confirmatory Phase 3 program remains planned, distinct from earlier completed clinical studies and expanded-access programs. The operating business was founded in 2013 and became publicly traded through its 2020 Tottenham SPAC combination. Headquarters are in Salt Lake City, with manufacturing and research in North East, Maryland. Current published leadership comprises 12 people and a nine-member board, with the CEO serving in both. | Salt Lake City, Utah, United States · North East, Maryland, United States |
 CLEO | CLEO operates in Fintech. | |
 Cleo Labs | Cleo Labs operates in SaaS. | |
 Cleric | Company operating in AI. | |
 Clerk | Developer Tools company. | San Francisco, CA, US |
 Cleva | | |
 Cleva Banking | Cleva is a fintech platform that helps people and businesses in emerging markets receive international payments, manage dollar accounts, use cards, exchange currencies, and save. | |
 Cleveland Clinic Innovations | Cleveland Clinic Innovations is the technology-commercialization arm of Cleveland Clinic, a nonprofit academic medical center operated by The Cleveland Clinic Foundation. Formed in2000, it advances caregiver inventions through assessment, technology development, intellectual-property protection, licensing, startup creation, strategic partnerships and venture investing. Its Cleveland Clinic Ventures team creates and invests in spinout companies and supports formation, management, governance, financing and strategic transactions. This profile represents the institutional commercialization and Ventures unit; public sources do not establish a separate independently capitalized venture fund manager. Its portfolio spans medical devices, diagnostics, therapeutics, digital health and artificial intelligence. Relevant examples include Enspire DBS Therapy’s stroke-rehabilitation neuromodulation, NeuroTherapia’s neuroinflammation therapies, AxoNeural’s spinal-cord-injury therapeutics, Infuseon’s brain drug-delivery catheter, Floreo’s virtual-reality developmental therapy, Bayesian Health’s predictive clinical AI and Dyania Health’s clinical-data AI. The current directory names20 leadership, business-development/licensing and Ventures staff. Chief D. Geoffrey Vince and Ventures Executive Director JD Friedland lead the commercialization and investing work. The Global Venture Philanthropy Fund is a donor-supported innovation program mentioned in Clinic publications; its size and close are not publicly disclosed in the reviewed sources, and it is not assumed to be a conventional closed LP venture fund. Healthcare-system assets, innovation outcomes, research budgets, licensing partnerships and venture capital committed to portfolio companies are not treated as manager fund-close cash. This unit is distinct from unrelated Cleveland Avenue and Cleveland Capital Management. Ohio’s2023 economic-development annualreport also names CCF Ohio BioValidation Funds I–VI as Foundation pre-seed investment capitalization vehicles, reporting state funds awarded, expenditures and cost share. Those figures and project-end dates are not treated as total LP commitments or fund-close dates. These government-backed capitalization vehicles and the philanthropic program are distinct from conventional closed LP venture funds. | Cleveland, Ohio, United States |
 Clever | | |
 CleverTap | | |
 Click Therapeutics | Click Therapeutics, Inc. develops prescription digital therapeutics using neuroscience, behavioral interventions, patient-centered software design and AI-enabled personalization. Founded in2012, it is headquartered in New York with a Boston office. Its products include the Otsuka collaboration Rejoyn for adjunctive major-depressive-disorder treatment, CT-132 for episodic migraine, acquired AspyreRx technology, and Boehringer Ingelheim collaboration Motivista (CT-155). FDA510(k) K254038 records Motivista clearance on July30,2026; the company announced it October5. Its indication is adjunctive treatment of negative schizophrenia symptoms in clinically stable adults under clinician care, not a general authorization of every pipeline program. Other programs remain at distinct development stages. Click SE extends its software platform to drug-related software and software-enhanced therapies. Published executives, board members and scientific advisers are represented separately; the October2026 SEC filing overrides a stale directory entry for resigned director Bruce Robertson. Financing records distinguish equity, notes, converted debt, loan proceeds, facility capacity and commercial collaboration funding. Better Therapeutics assets were acquired in2024; that asset purchase does not imply a legal merger or a disclosed acquisition price. | New York, New York, United States · Boston, Massachusetts, United States |
 Clickhouse | ClickHouse is an open-source columnar database and cloud analytics company for real-time warehousing, observability and AI workloads. Spun out of Yandex and incorporated in 2021 by Aaron Katz, Alexey Milovidov and Yury Izrailevsky. Khosla Ventures participated in its $400 million Series D in January 2026. | San Francisco, California |
 clickhouse-cloud | | |
 ClickUp | | |
 Climate AI | Company operating in Climate & Energy. | |
 Climatiq | Climatiq operates in Climate & Energy. | |
 Cline | Fintech company. | |
 Clinikally | | |
 Clio | Founded in 2008 as a Web-based practice management software for small law firms, Clio is the global leader in legal software, offering an intelligent, AI‑enabled platform for practice management, client intake, billing, and trusted legal research. | 🇨🇦 · Canada |
 Clip | Company operating in Media & Entertainment. | |
 Clip Health | Company operating in Healthcare. | |
 Clipboard | | |
 Clipboard Health | | |
 Clippership | | |
 CliqueCustom Airdrop ToolingB2B | Company operating in Social & Community. | |
 Cloaked | Cybersecurity company. | |
 Clockwise | Clockwise operates in SaaS. | |
 Clockwork Labs | Clockwork Labs operates in Gaming. | |
 Clootrack | Analyzes customer feedback using AI to help businesses understand customer experiences and identify operational improvements. | |
 Cloover | Cloover operates in Climate & Energy. | |
 Closed Loop Medicine | Company operating in Healthcare. | |
 CloseFactor | | |
 Cloud Capital | Cloud Capital operates in Fintech. | |
 Cloud Capital Technologies | Provides cloud spending visibility, forecasts and financial management tools for finance teams. | |
 Cloud NC | Cloud NC operates in Manufacturing. | |
 Cloud&Heat | Infrastructure & Cloud company. | |
 CloudBees | | |
 CloudCruise | | |
 Cloudera | Cloudera operates in Data & Analytics. | |
 CloudForge | Builds AI-assisted business software for metal distributors and service centers, helping teams manage sales, customer relationships and operational workflows. | |
 CloudGenix | | |
 CloudGenix, Inc. | | |
 Cloudify | Infrastructure & Cloud company. | |
 Cloudnatix | Cloudnatix operates in Infrastructure & Cloud. | |
 CloudPassage | CloudPassage operates in Cybersecurity. | |
 CloudQuery | CloudQuery operates in Data & Analytics. | |
 Clouds of Care | Ghent neuroscience and medical-technology company providing electrophysiology software, digital health tools and clinical-development services for central nervous system disorders. Its platform combines EEG and related measurements with data analytics and operational workflows for clinical trials and care. Founded as Epilog, it adopted the Clouds of Care brand in 2023. | |
 Cloudsmith | Developer Tools company. | |
 CloudTalk | CloudTalk provides a modern business phone system and virtual call center for growing companies, combining VoIP with AI features like transcription and real-time coaching, advanced dialing and IVR, and deep CRM integrations, helping teams deliver faster, higher‑quality support and sales. | 🇸🇰 · Slovakia |
 Cloudthread | | |
 Clove | Clove operates in Consumer. | UK |
 Clover Health | Healthcare company. | Jersey City, NJ |
 Clubee | SaaS company. | |
 Clubhouse | Clubhouse operates in Social & Community. | |
 Clue | Clue operates in Healthcare. | |
 Clueso | | |
 Clumio | Clumio provides cloud-native backup and recovery software for data and applications running in public clouds. | |
 Cluster | 「cluster (クラスター)」はスマートフォンやPC、VR機器など様々な環境からバーチャル空間に集って遊べるメタバースプラットフォームです。音楽ライブや発表会などのイベントの他、いつでも参加できるバーチャルワールドでチャットやゲームを楽しめます。 | |
 Clustree | | |
 Clustrix | | |
 Clutch | Universal non-human identity security: visibility, risk, remediation, and zero-trust for API keys, secrets, and service accounts. | Tel Aviv, Israel |
 Clutch | | |
 Clutch Security | | |
 Clutter | Clutter operates in Logistics & Supply Chain. | |
 Clyde Biosciences | Provides cardiac safety testing and drug discovery services using its CellOPTIQ platform to measure electrical activity, calcium handling and contraction in human-derived cardiomyocytes. | |
 clypd | Marketing & Advertising company. | Dallas, TX, US |
 Cmd | | |
 CMR Surgical | Medical-robotics company developing the Versius modular surgical robot for minimally invasive surgery. | |
 CMS Medical Venture Investment (HK) Limited | CMS Medical Venture Investment (HK) Limited is the Hong Kong corporate investment-holding vehicle named as an actual shareholder and investor in healthcare and life-science companies. It is distinct from Cayman-incorporated China Medical System Holdings Limited, the group’s operating and listed parent, and from similarly named BVI and Singapore companies. A2019 joint SEC Schedule13D and2022 Gelesis Schedule13G confirm the Hong Kong vehicle as a wholly owned CMS subsidiary and direct holder of investments; indirect parent beneficial ownership is not a second paid check. The 2019 filing identifies its principal business address as Unit2106,21/F, IslandPlaceTower,510King’sRoad,NorthPoint,HongKong. Its published subsidiary governance comprises two named directors, LamKong and HuaizhengPeng, historically confirmed2019; Peng additionally signs its2022 filing as director. The current CMS group biographies independently identify Lam as group founder/chairman/chief executive and Peng as chief business officer, but those current parent positions are not asserted as new current subsidiary operating roles. This record uses authentic CMS group branding with explicit parent-brand qualification because no independently branded subsidiary logo or dedicated subsidiary site was located. A&B(HK)CompanyLimited and its BVI parent are separate investment entities associated with LamKong; they are not CMSHK aliases or automatically wholly owned CMS subsidiaries. In2019 CMSHK and A&BHK each independently paid approximately GBP4M for Midatech shares/warrants from their own working capital. The parent and Lam made no direct purchases in that transaction, and commercial licensing milestones are not equity cash. Midatech and Gelesis are historical portfolio evidence; historical holdings do not prove current ownership or a new financing. Actual2018 Acticor SeriesB participation is sourced by issuer release and linked separately, with individual check unknown. Acticor entered judicial liquidation in January2025; no clinical efficacy or current operation is implied by this historical investment. Corporate paid-up share capital, group AUM and partner license capacity are not LP fund closes. No pooled external fund vehicles, independent subsidiary staff directory or exact current subsidiary directors’ tenure were disclosed in the reviewed sources. | Hong Kong |
 CNEX Labs | | |